Dr. Blair A Jobe is the Director of the Esophageal and Lung Institute and specializes in the field of minimally invasive surgery and endoscopic therapy for the treatment of esophageal cancer, Barrett's esophagus, esophageal mobility disorders, and gastroesophageal reflux disease (GERD). He is a nationally renowned pioneer in this field and is a prolific medical researcher and international lecturer.

Dr. Jobe is the principal investigator for two NIH grants that focus on improving early detection of esophageal cancer and the development of serum and tissue biomarkers, a precursor to a blood test for the early detection and treatment of esophageal cancer.

In 2015, Dr. Jobe received the Pittsburgh Business Times' Health Care Heroes award in the Health Care Innovation – Individual category for his discovery of four protein biomarkers, which resulted in highly accurate and inexpensive findings in determining whether or not cancer was present. He is a graduate of Creighton University School of Medicine and Loyola Marymount University and completed his residency at Oregon Health and Sciences University.

He is Board certified by the American Board of Surgery and is located at AHN Surgery, ACMH Hospital, 1 Nolte Dr, #110, Kittanning, PA 16201. Phone:(724) 548-5002.